Can we improve our ability to assess primary tumor stage of prostate cancer in patients with MRI-visible lesions? Development and external validation of a novel T-stage classification based on clinical and MRI findings

MLA

G. Gandaglia, et al. “Can We Improve Our Ability to Assess Primary Tumor Stage of Prostate Cancer in Patients with MRI-Visible Lesions? Development and External Validation of a Novel T-Stage Classification Based on Clinical and MRI Findings.” European Urology Open Science, vol. 19, no. 1722–1723, July 2020, pp. e1722–23. EBSCOhost, https://doi.org/10.1016/S2666-1683(20)33753-8.

APA

G. Gandaglia, G. Ploussard, M. Valerio, A. Mattei, G. Marra, J. Beauval, B. Malavaud, M. Roumiguié, A. Marquis, L. Afferi, M. Moschini, N. Fossati, L. Nocera, A. Stabile, S. Scuderi, G. Rosiello, A. Rakauskas, R. Van Den Bergh, F. De Cobelli, … A. Briganti. (2020). Can we improve our ability to assess primary tumor stage of prostate cancer in patients with MRI-visible lesions? Development and external validation of a novel T-stage classification based on clinical and MRI findings. European Urology Open Science, 19(1722–1723), e1722–e1723. https://doi.org/10.1016/S2666-1683(20)33753-8

Chicago

G. Gandaglia, G. Ploussard, M. Valerio, A. Mattei, G. Marra, J. Beauval, B. Malavaud, et al. 2020. “Can We Improve Our Ability to Assess Primary Tumor Stage of Prostate Cancer in Patients with MRI-Visible Lesions? Development and External Validation of a Novel T-Stage Classification Based on Clinical and MRI Findings.” European Urology Open Science 19 (1722–1723): e1722–23. doi:10.1016/S2666-1683(20)33753-8.